What we achieved in 2025, together
Date
Research news
Date
Researchers in Norway have published results from an early stage clinical study looking at the potential of a dietary supplement for people with Parkinson's.
Date
Researchers, including scientists from Queen's University Belfast, have discovered that people with Parkinson's who eat more flavonoids may have a longer life expectancy.
Date
Researchers in the Netherlands discover that regular exercise may improve Parkinson’s symptoms by creating connections between areas of the brain affected by the condition.
Date
If you test positive for coronavirus, you may be able to take part in a UK-wide trial to find out if antiviral drugs can help people recover faster.
Date
Scientists have shown a pioneering test could diagnose Parkinson's correctly in its early stages.
Date
The first participant has been recruited to a pioneering clinical trial which is testing a new drug called NLX-112 to investigate its potential for people with Parkinson’s.
Date
UCB, a global pharmaceutical company, has joined forces with Parkinson's UK, and the Parkinson's Foundation in the US, to establish a Patient Engagement Council for Parkinson's Research.
Date
We’ve developed an interactive communications toolkit to help researchers in all areas of health research to keep in touch with their participants. It is supported by the Health Research Authority (HRA) as part of the Make It Public strategy.
Date
Results show that atomoxetine, a drug used to treat attention deficit hyperactivity disorder (ADHD), could improve thinking and impulsiveness in Parkinson’s.
Date
Researchers in the United States have shown that a compound found in fruit - farnesol - has the potential to play a protective role to dopamine-producing brain cells.